SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
94 hedge funds and large institutions have $53.1M invested in Syros Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 31 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
68% less capital invested
Capital invested by funds: $166M → $53.1M (-$113M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
94
Holding in Top 10
–
Calls
$33K
Puts
$14K
Top Buyers
| 1 | +$975K | |
| 2 | +$595K | |
| 3 | +$499K | |
| 4 |
Two Sigma Investments
New York
|
+$164K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$155K |
Top Sellers
| 1 | -$5.99M | |
| 2 | -$4.21M | |
| 3 | -$3.78M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$2.93M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$637K |